EP3698791
Samsetning sem inniheldur betahistín til gjafar í nefhol
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.2.2018EP published:
25.10.2023EP application number:
20170448.3
EP translation filed:
3.1.2024Grant published:
15.2.2024EPO information:
European Patent Register
Max expiry date:
1.2.2038Expiry date:
1.2.2027Next due date:
28.2.2027
Title in English:
INTRANASAL COMPOSITION COMPRISING BETAHISTINELanguage of the patent:
English
Timeline
Today
2.2.2018EP application
25.10.2023EP Publication
3.1.2024Translation submitted
15.2.2024Registration published
1.2.2027Expires
Owner
Name:
Otolanum AGAddress:
Bahnhofstrasse 21, 6300 Zug, CH
Inventor
Name:
WRAIGHT, Christopher JohnAddress:
Blackburn, Victoria 3130, AU
Name:
MEYER, ThomasAddress:
4528 Zuchwil, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762453931 PDate:
2.2.2017Country:
US
Classification
Categories:
A61K 31/4402, A61P 27/16, A61K 47/32, A61K 9/08
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 23.2.2024
Expires: 1.2.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 13.1.2025
Expires: 1.2.2026
Payer: Árnason Faktor ehf.
Number: 9
Paid: 4.2.2026
Expires: 1.2.2027
Payer: Árnason Faktor ehf.